Regeneron Pharmaceuticals (REGN) Net Income towards Common Stockholders (QoQ) (2009 - 2026)
Regeneron Pharmaceuticals (REGN) Net Income towards Common Stockholders (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.90% |
| Dec 31, 2025 | -42.15% |
| Sep 30, 2025 | 4.92% |
| Jun 30, 2025 | 72.08% |
| Mar 31, 2025 | -11.88% |
| Dec 31, 2024 | -31.55% |
| Sep 30, 2024 | -6.40% |
| Jun 30, 2024 | 98.38% |
| Mar 31, 2024 | -37.74% |
| Dec 31, 2023 | 15.06% |
| Sep 30, 2023 | 4.07% |
| Jun 30, 2023 | 18.42% |
| Mar 31, 2023 | -31.68% |
| Dec 31, 2022 | -9.01% |
| Sep 30, 2022 | 54.41% |
| Jun 30, 2022 | -12.47% |
| Mar 31, 2022 | -56.33% |
| Dec 31, 2021 | 36.56% |
| Sep 30, 2021 | -47.33% |
| Jun 30, 2021 | 177.88% |